Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Children symbols : BNTX save search
Pfizer and BioNTech's Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster Receives Health Canada Authorization for Children 5 Through <12 Years of Age
Published: 2022-12-09 (Crawled : 00:20) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
covid-19 children vaccine canada health authorization
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.16 130
|
Communications
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -0.12%
H: 3.36%
C: 3.19%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.37%
H: 5.31%
C: 5.26%
covid-19 fda children vaccine authorization
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union
Published: 2022-11-10 (Crawled : 15:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -3.15%
H: 4.22%
C: 4.22%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 1.72%
H: 0.47%
C: -0.31%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -4.59%
H: 3.28%
C: 3.06%
covid-19 chmp children vaccine positive
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union
Published: 2022-10-19 (Crawled : 16:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -0.41%
H: 0.36%
C: -1.82%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -1.37%
H: 0.37%
C: -6.97%
comirnaty comirnaty® chmp children positive
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age
Published: 2022-10-12 (Crawled : 15:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 0.41%
H: 2.49%
C: -0.14%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 3.4%
H: 4.91%
C: 2.06%
covid-19 fda children vaccine authorization
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age
Published: 2022-09-26 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 5.77%
H: 0.0%
C: -2.27%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -0.61%
H: 1.19%
C: 0.05%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -2.29%
H: 0.35%
C: -0.67%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -1.21%
H: 4.5%
C: 0.67%
fda children vaccine application authorization
Pfizer and BioNTech Announce Updated COVID-19 Vaccine Data Supporting Efficacy in Children 6 Months through 4 Years of Age
Published: 2022-08-23 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.16 130
|
Communications
|
| O: -0.87%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 1.75%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -0.98%
H: 0.21%
C: -0.85%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.13%
H: 1.14%
C: -0.84%
covid-19 children vaccine
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
Published: 2022-06-17 (Crawled : 14:00) - globenewswire.com
FNCTF | News | $11.16 130
|
Communications
|
| O: -4.49%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -1.76%
H: 5.75%
C: 5.5%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 1.39%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
covid-19 fda children vaccine authorization emergency use authorization
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third Dose
Published: 2022-05-23 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -3.11%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 2.55%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.85%
H: 0.06%
C: -1.91%
covid-19 children vaccine
Pfizer, BioNTech Seek Approval for Boosters in Children Following Positive Data
Published: 2022-04-14 (Crawled : 15:20) - biospace.com/
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.67%
H: 1.98%
C: -1.62%
children approval positive
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of Their COVID-19 Vaccine in Children 5 Through 11 Years of Age
Published: 2022-04-14 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 3.34%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -1.56%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.67%
H: 1.98%
C: -1.62%
covid-19 children vaccine response
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union
Published: 2021-11-25 (Crawled : 13:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.765 -1.94% 950K
|
Health Technology
| Email alert
Add to watchlist
comirnaty comirnaty® europe positive chmp children
Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5 Through 11 Years
Published: 2021-10-29 (Crawled : 22:00) - globenewswire.com
SNYNF | News | $94.25 480
|
Health Technology
| Email alert
Add to watchlist
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.765 -1.94% 950K
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 130
|
Communications
| Email alert
Add to watchlist
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
| Email alert
Add to watchlist
covid fda children vaccine merge emergency use authorization
FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years
Published: 2021-10-26 (Crawled : 23:00) - globenewswire.com
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: 0.39%
H: 0.23%
C: -1.13%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.91%
H: 0.06%
C: -1.04%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.4%
H: 1.16%
C: -5.35%
covid fda children vaccine merge emergency use authorization
Health Canada receives submission from Pfizer-BioNTech to authorize the use of Comirnaty COVID-19 vaccine in children 5 to 11 years of age
Published: 2021-10-18 (Crawled : 01:00) - biospace.com/
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -0.94%
H: 6.44%
C: 6.42%
covid children vaccine submission comirnaty®
Pfizer and BioNTech Submit Initial Data to U.S. FDA From Pivotal Trial of COVID-19 Vaccine in Children 5 to <12 Years of Age
Published: 2021-09-28 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.25 -0.27% 12M
|
Health Technology
|
| O: -1.15%
H: 0.49%
C: -0.07%
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: 0.15%
H: 0.06%
C: -0.6%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -4.36%
H: 1.09%
C: -5.85%
covid fda children vaccine trial
Pfizer and BioNTech Announce Positive Topline Results from Pivotal Trial of COVID-19 Vaccine in Children 5 to 11 Years
Published: 2021-09-20 (Crawled : 11:00) - globenewswire.com
SNY | News | $46.765 -1.94% 950K
|
Health Technology
|
| O: -1.35%
H: 0.0%
C: 0.0%
BNTX | News | $88.185 -0.35% 140K
|
Health Technology
|
| O: -8.02%
H: 3.64%
C: -0.64%
covid positive results topline children vaccine trial
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.85 51.79% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
SKIL 4 | $8.045 40.89% 230K
|
Information
MULN | News | $3.805 39.38% 11M
|
Information
RILY | $30.01 38.17% 11M
|
Finance
MTC | $3.04 35.71% 6.7M
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.